Jennifer A A Gubbels

The detection, treatment, and biology of epithelial ovarian cancer

M. Patankar, J. Connor, A. Kapur, 2010, Journal of ovarian research.

Differential internalization of hu14.18‐IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting

M. Patankar, S. Gillies, R. Reisfeld, 2011, Journal of leukocyte biology.

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

C. Rancourt, M. Patankar, S. Horibata, 2010, Molecular Cancer.

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

Mitchell Ho, I. Pastan, Byungkook Lee, 2006, Molecular Cancer.

Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)

C. Rancourt, M. Patankar, J. Connor, 2007, Immunology.

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance

R. Drapkin, M. Hirsch, M. Iwanicki, 2016, Oncogenesis.

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies

C. Rancourt, Michaela Zwick, M. Patankar, 2009, Journal of ovarian research.